Date | Title | Description | Source |
30.04.2024 | HanAll Biopharma Reports Q1 2024 Financial Results and Provi... | Delivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billio... | en.prnasia... |
04.04.2023 | Highschool Startup Begins User Testing of an Instant and Mob... | Vytal.ai begins user testing for NeurEye, a 30-second test for ocular biometrics indicative of neuro... | einpresswi... |
28.02.2023 | Vivek Ramaswamy, a biotech millionaire running against Trump... | Vivek Ramaswamy at CPAC in Dallas, Texas, on August 5, 2022. Brian Snyder/Reuters
Vivek Ramaswamy an... | businessin... |
10.06.2022 | “You are able to think big only if you think independently.”... | | startuptic... |
21.09.2021 | Roivant Sciences Reports First Fiscal Quarter 2021 Financial... | BASEL, Switzerland and LONDON and NEW YORK, Sept. 21, 2021 /PRNewswire/ -- Roivant Sciences Ltd. (&q... | salamancap... |
09.06.2021 | MONTES ARCHIMEDES ACQUISITION CORP.
Montes Archimedes Acqui... | NEW YORK and BASEL, Switzerland, June 9, 2021 /PRNewswire/ -- Roivant Sciences today announced that ... | marketscre... |
06.05.2021 | SUMITOMO DAINIPPON PHARMA CO., LTD.
Sumitomo Dainippon Phar... | May 6, 2021
Sumitomo Dainippon Pharma Co., Ltd.
Sumitomo Dainippon Pharma Announces Investment in Sp... | marketscre... |
04.05.2021 | Swiss biotech company Roivant Sciences to go public via $7.3... | Roivant Sciences, a biopharmaceutical & healthcare technology company, has announced that it is ... | siliconcan... |
03.05.2021 | Roivant Sciences and Montes Archimedes Acquisition Corp. (MA... | NEW YORK, MENLO PARK, Calif., LONDON, and BASEL, Switzerland, May 3, 2021 /PRNewswire/ -- Roivant Sc... | salamancap... |
03.05.2021 | Roivant Sciences to go public via $7.3 billion deal | Montes Archimedes Acquisition Corp. (MAAC) is a so-called SPAC, a special purpose acquisition compan... | startuptic... |
03.05.2021 | Roivant Sciences to go public via $7.3 billion deal | | startuptic... |
03.05.2021 | Roivant Sciences to go public through $7.3 billion SPAC deal | Roivant Sciences, the biotech company once pitched as a Berkshire Hathaway for the pharmaceutical in... | statnews.c... |
03.05.2021 | Today in European Tech: Roivant to go public in $7.3 billion... | Hello!
Here's what happened today in European Tech. Deals
- Roivant Sciences has agreed to go public... | tech.eu/fr... |
26.02.2021 | Roivant Grows Computational Drug Discovery Engine with Acqui... | NEW YORK and BOSTON and BASEL, Switzerland, Feb. 26, 2021 /PRNewswire/ -- Roivant Sciences today ann... | oaoa.com/n... |
26.02.2021 | Roivant Grows Computational Drug Discovery Engine with Acqui... | – Leading computational physics-based platform for design and optimization of small molecules bolste... | venturebea... |
26.02.2021 | Roivant extends AI drug discovery reach with $450M Silicon T... | New York and Basel, Switzerland-based Roivant is acquiring Silicon Therapeutics, a computational dru... | medcitynew... |
26.02.2021 | Roivant Grows Computational Drug Discovery Engine with Acqui... | NEW YORK & BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Feb 26, 2021--
Roivant Sciences tod... | oaoa.com/n... |
09.12.2020 | South Korean conglomerate injects $200 million in Roivant | | startuptic... |
09.12.2020 | South Korean conglomerate injects $200 million in Roivant | Roivant Sciences develops medicines by leveraging the Roivant platform to launch "Vants" –... | startuptic... |
07.12.2020 | Roivant gets $200M for major push into protein degradation | Roivant Sciences has secured $200 million to advance its protein degradation ambitions. Armed with t... | fiercebiot... |
07.12.2020 | Roivant gets $200M for major push into protein degradation
... | Roivant Sciences has secured $200 million to advance its protein degradation ambitions. Armed with t... | fiercebiot... |
15.10.2020 | It’s Raining Biotech SPACs! | SPACs are all the rage today. With the IPO market booming and public investors seeking better return... | forbes.com... |
01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Figh... | Alain Mérieux, founder of BioMérieux.AFP via Getty Images | forbes.com... |
03.01.2020 | Roivant closes USD $3 billion deal with Sumitomo Dainippon P... | | startuptic... |
03.01.2020 | Roivant closes USD $3 billion deal with Sumitomo Dainippon P... | Sumitovant will operate as a wholly owned subsidiary of Sumitomo Dainippon Pharma and will be the pa... | startuptic... |
06.09.2019 | Sumitomo pays $3B to Vivek Ramaswamy’s Roivant under new all... | The alliance will be wholly owned by Sumitomo, which is also taking over Myovant Sciences, Urovant S... | medcitynew... |
26.08.2019 | Venture-backed Modis Therapeutics Acquired By Publicly-held ... | 7 Shares Email Facebook Twitter LinkedIn
Modis Therapeutics, a venture-backed biopharma company, is ... | news.crunc... |
04.04.2019 | Vivek Ramaswamy launches yet another Vant, this time in ... | Vivek Ramaswamy’s company-churning shop Roivant is operating at full steam. After unveilin... | endpts.com... |
13.11.2018 | Roivant raises $200M in equity financing, valuing company at... | Most of the latest round of financing came from new investors NovaQuest Capital Management and RTW I... | medcitynew... |
13.11.2018 | Roivant Sciences Announces $200M Round | Roivant Sciences, a Basel, Switzerland-based developer of rapidly developing innovative medicines th... | finsmes.co... |
13.11.2018 | Roivant raises $200M, at $7B valuation, to add to startup ro... | Roivant Sciences has raised $200 million to roll out another round of startups. The financing, which... | fiercebiot... |
13.11.2018 | Investors Bet $200M On Roivant, A Biopharma Company Now Valu... | 12 Shares Email Facebook Twitter LinkedIn
Swiss biopharmaceutical company Roivant Sciences has raise... | news.crunc... |
13.11.2018 | Biotech holding company Roivant Sciences raised $200M in fun... | Roivant Sciences has had a bumpy couple of years, but that isn’t stopping investors from pouring mor... | techcrunch... |
13.11.2018 | Roivant raises $200M, at $7B valuation, to add to startup ro... | Roivant Sciences has raised $200 million to roll out another round of startups. The financing, which... | fiercebiot... |
27.03.2018 | Roivant bags China rights to Nabriva's antibiotic; Sin... | → Roivant Sciences is doubling down on infectious diseases and the China market with a licen... | endpts.com... |
19.01.2018 | Roivant Sciences to join BaseLaunch Accelerator as Healthcar... | | startuptic... |
06.10.2017 | Roivant looks to quickly turn the page, starting with a Phas... | A new hormonal therapy designed to treat uterine fibroids called relugolix has finished a Phase 3 st... | techcrunch... |
03.10.2017 | What SoftBank really wants | Some in Silicon Valley aren’t quite sure what to make of SoftBank and its massive, roughly $100 bill... | techcrunch... |
26.09.2017 | Roivant receives bad news — and so does SoftBank | Last month, SoftBank, through its massive Vision Fund, led the single biggest private financing roun... | techcrunch... |
10.08.2017 | SoftBank's Vision Fund Courts Startups That Mix Data and Pha... | (Bloomberg) -- SoftBank Group Corp.’s Vision Fund is targeting a range of investments in startups th... | bloombergq... |
10.08.2017 | Roivant Sciences Raises $1.1 Billion | | startuptic... |
09.08.2017 | Roivant Sciences Raises $1.1 Billion in Equity Funding | Roivant Sciences, a global healthcare company, raised $1.1 billion in equity funding.
The round was ... | finsmes.co... |
09.08.2017 | Term Sheet — Wednesday, Aug. 9 | ET CETERA
Good morning! I’m attending to some magazine duties today, so here’s some news from my For... | fortune.co... |
09.08.2017 | Roivant, which creates companies around abandoned drugs, jus... | Roivant Sciences, a three-year-old, Basel, Switzerland-based company aiming to one day be a giant ho... | techcrunch... |
17.04.2017 | Enzyvant secures new Regenerative Medicine Advanced Therapy ... | North Carolina-based Humacyte claimed the first RMAT designation on March 20, 2017, for its investig... | medcitynew... |
10.04.2017 | Axovant hires ex-Medivation CEO as it nears Phase 3 Alzheime... | That pipeline and commercialization experience could go a long way at Axovant.
Indeed, Wall Street s... | medcitynew... |
06.01.2017 | The billion-dollar pharma startup that Silicon Valley has to... | When it comes to millennials and healthcare companies, recent history gives plenty of reason for pau... | techcrunch... |
29.12.2016 | Ambitious young biotech group establishes global headquarter... | | startuptic... |
21.12.2016 | Is biopharma’s Midas man Vivek Ramaswamy building a new... | Vivek Ramaswamy
One of Vivek Ramaswamy’s fledgling, pre-IPO “vant” companies has swung anothe... | endpts.com... |
27.10.2016 | Myovant Sciences rallies $218 million biotech IPO | At the heart of Myovant’s impressive stock price is an agreement with Takeda Pharmaceuticals, which ... | medcitynew... |
- | Today in European Tech: Roivant to go public in $7.3 billion... | Hello!
Here's what happened today in European Tech. Deals
- Roivant Sciences has agreed to go public... | tech.eu/20... |
- | Axovant hires ex-Medivation CEO as it nears Phase 3 Alzheime... | Five months out from a potentially pivotal data readout on its lead candidate for Alzheimer’s diseas... | medcitynew... |
- | Roivant raises $200M in equity financing, valuing company at... | A company developing drugs across a wide variety of therapeutic areas – including several that are i... | medcitynew... |
- | Roivant extends AI drug discovery reach with $450M Silicon T... | Roivant Sciences has technology that uses computer modeling to design drugs that harness the body’s ... | medcitynew... |
- | Sumitomo pays $3B to Vivek Ramaswamy’s Roivant under new all... | A Japanese drugmaker plans to acquire several companies from Vivek Ramaswamy’s Vant family of firms ... | medcitynew... |
- | Roivant in Talks to Sell Stomach Drug to Roche in Deal Value... | - | wsj.com/ar... |
- | Myovant Sciences rallies $218 million biotech IPO | As the nation slept, women’s health company Myovant Sciences quietly completed the largest biotech i... | medcitynew... |
- | Enzyvant secures new Regenerative Medicine Advanced Therapy ... | There are countless nuggets of healthcare gold buried within the almost 1000-page 21st Century Cures... | medcitynew... |